Vaccination programs plunge ahead

Visual form

Three-series line chart.

Layout / body structure

The chart is one line chart with time running from the end of Q1 to the end of Q2 and the end of July. Reader follows three separate country trajectories across the shared timeline to compare how quickly vaccine availability is expected to reach most adults.

What is being compared

It compares expected COVID-19 vaccine availability for adults in the European Union, the United Kingdom, and the United States during 2021.

Measurement system

The measure is percent of adults for whom doses are available. Each country is shown as a line with marked endpoints, and the vertical position of each marker indicates the availability level reached by each date.

Visible structure inside the graphic

The US, UK, and EU each have a distinct colored trajectory, and the chart uses only a few key points rather than dense monthly observations. A black note box in the lower-right portion explains that the definitions differ slightly because the UK line refers to first dose only while the US and EU refer to full courses.

Main takeaway from the visual

Vaccines are expected to become available for most adults across all three regions, but the timing differs markedly. The US rises fastest toward full availability, the UK reaches full coverage later under a first-dose strategy, and the EU trails both by the end of Q2.

Key standout values or extremes

At the end of Q1, the chart shows roughly 46 percent for the US, 52 percent for the UK first-dose path, and about 14 percent for the EU. The US reaches 100 percent by the end of Q2, the UK reaches 100 percent by the end of July, and the EU rises to about 68 percent by the end of Q2.

Controls / sequence, when applicable

This is a static chart image with no in-chart controls to operate.

Companion media, when applicable

There is no separate companion audio or video; the chart image is the full visual on this page.